BRIDGEWATER, N.J., Feb. 23, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. ET on Wednesday, March 2 to provide a business update and discuss its fourth-quarter and full-year 2010 financial and operational results.
